Improving participation of diverse communities in precision medicine initiatives
Official title: MITRE CORP:1105900 [24-002923]
Funded at Mitre Corporation · NIH-11199245 · Data updated 2026-11-12
This study is all about making sure that people from diverse backgrounds, especially Hispanic and African American communities, can take part in important health research, and it’s looking for ways to help health centers better connect with these groups so everyone’s voice is heard in medicine.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mitre Corporation NIH-funded |
| Lab location | 1 site (Mc Lean, United States) |
| Project start | September 9, 2024 |
| Project end | September 8, 2025 |
| Funding year | 2024 |
| Award (this year) | $5,439,995 |
| NIH project number | 75N98024F00371-0-0-1 |
| Project ID | NIH-11199245 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals from historically underrepresented communities, including Hispanic and African American populations.
✕Less likely to help
Patients who do not belong to underrepresented communities or those who are not interested in participating in research initiatives may not benefit from this research.
What this research studies
This research focuses on the All of Us Research Program, which aims to create a diverse cohort for precision medicine by ensuring that historically underrepresented communities, such as Hispanic and African American populations, are actively engaged in biomedical research. The program seeks to identify effective strategies for Federally Qualified Health Center (FQHC) Health Provider Organizations to enhance enrollment and retention of these populations. By addressing barriers to participation, the initiative aims to reflect the rich diversity of America in health research. Patients may be involved in providing insights and feedback on how to improve outreach and engagement efforts.
Why it matters
Potential benefit: If successful, this research could lead to more inclusive and representative health studies, ultimately improving health outcomes for diverse populations.
How similar studies have gone: Previous initiatives aimed at increasing diversity in clinical trials have shown promise, indicating that targeted outreach can improve participation rates among underrepresented groups.
Where this research is happening
-
Mitre Corporation
Mc Lean, United States Active
Researchers
- Principal investigator: Kunzman, Jon — Mitre Corporation
- Study coordinator: Kunzman, Jon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.